CA Patent
CA961052A — N-2-ethylhexyl-n'-aryl ureas and preparation containing them
Assigned to BASF Schweiz AG · Expires 1975-01-14 · 51y expired
What this patent protects
Patent listed against Velsipity.
Drugs covered by this patent
- Velsipity (Etrasimod Arginine) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.